nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A7—Ifosfamide—testicular cancer	0.0757	0.16	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0757	0.16	CbGbCtD
Quetiapine—CYP3A5—Ifosfamide—testicular cancer	0.0568	0.12	CbGbCtD
Quetiapine—CYP2C19—Ifosfamide—testicular cancer	0.0458	0.0969	CbGbCtD
Quetiapine—ADRA1B—vas deferens—testicular cancer	0.0403	0.29	CbGeAlD
Quetiapine—ABCB1—Dactinomycin—testicular cancer	0.0313	0.0662	CbGbCtD
Quetiapine—CYP3A5—Etoposide—testicular cancer	0.0272	0.0574	CbGbCtD
Quetiapine—HTR7—vas deferens—testicular cancer	0.0235	0.169	CbGeAlD
Quetiapine—CYP3A4—Ifosfamide—testicular cancer	0.0222	0.0468	CbGbCtD
Quetiapine—ABCB1—Vinblastine—testicular cancer	0.0196	0.0415	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—testicular cancer	0.0185	0.0391	CbGbCtD
Quetiapine—ABCB1—Cisplatin—testicular cancer	0.018	0.038	CbGbCtD
Quetiapine—ABCB1—Etoposide—testicular cancer	0.0177	0.0374	CbGbCtD
Quetiapine—H1F0—semen—testicular cancer	0.0135	0.0976	CbGeAlD
Quetiapine—ABCB1—Doxorubicin—testicular cancer	0.0121	0.0255	CbGbCtD
Quetiapine—CYP3A4—Vinblastine—testicular cancer	0.0118	0.0248	CbGbCtD
Quetiapine—ABCB1—Methotrexate—testicular cancer	0.0117	0.0247	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—testicular cancer	0.0114	0.024	CbGbCtD
Quetiapine—CYP3A4—Etoposide—testicular cancer	0.0106	0.0224	CbGbCtD
Quetiapine—HTR7—vein—testicular cancer	0.00997	0.0718	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—testicular cancer	0.00722	0.0153	CbGbCtD
Quetiapine—HTR2A—vein—testicular cancer	0.00621	0.0448	CbGeAlD
Quetiapine—H1F0—embryo—testicular cancer	0.00306	0.022	CbGeAlD
Quetiapine—DRD4—testis—testicular cancer	0.00293	0.0211	CbGeAlD
Quetiapine—H1F0—seminal vesicle—testicular cancer	0.00287	0.0207	CbGeAlD
Quetiapine—HTR1E—female gonad—testicular cancer	0.00285	0.0206	CbGeAlD
Quetiapine—CHRM4—testis—testicular cancer	0.00222	0.016	CbGeAlD
Quetiapine—DRD5—female gonad—testicular cancer	0.00218	0.0157	CbGeAlD
Quetiapine—H1F0—gonad—testicular cancer	0.00207	0.015	CbGeAlD
Quetiapine—H1F0—female gonad—testicular cancer	0.00169	0.0121	CbGeAlD
Quetiapine—ADRA2C—seminal vesicle—testicular cancer	0.00163	0.0117	CbGeAlD
Quetiapine—H1F0—testis—testicular cancer	0.0015	0.0108	CbGeAlD
Quetiapine—ADRA2A—seminal vesicle—testicular cancer	0.0013	0.00936	CbGeAlD
Quetiapine—HTR7—gonad—testicular cancer	0.00128	0.00923	CbGeAlD
Quetiapine—HTR2A—embryo—testicular cancer	0.00118	0.00848	CbGeAlD
Quetiapine—CHRM3—female gonad—testicular cancer	0.00109	0.00788	CbGeAlD
Quetiapine—H1F0—lymph node—testicular cancer	0.00108	0.00781	CbGeAlD
Quetiapine—CHRM3—testis—testicular cancer	0.000969	0.00699	CbGeAlD
Quetiapine—ADRA2C—female gonad—testicular cancer	0.000956	0.00689	CbGeAlD
Quetiapine—ADRA2A—gonad—testicular cancer	0.000939	0.00677	CbGeAlD
Quetiapine—HTR7—testis—testicular cancer	0.000923	0.00665	CbGeAlD
Quetiapine—DRD2—testis—testicular cancer	0.000872	0.00629	CbGeAlD
Quetiapine—ADRA2C—testis—testicular cancer	0.000848	0.00611	CbGeAlD
Quetiapine—CYP3A5—female gonad—testicular cancer	0.0008	0.00577	CbGeAlD
Quetiapine—HTR2A—gonad—testicular cancer	0.000798	0.00575	CbGeAlD
Quetiapine—HRH1—female gonad—testicular cancer	0.000777	0.0056	CbGeAlD
Quetiapine—ABCB1—embryo—testicular cancer	0.000771	0.00555	CbGeAlD
Quetiapine—ADRA2A—female gonad—testicular cancer	0.000763	0.0055	CbGeAlD
Quetiapine—ABCB1—seminal vesicle—testicular cancer	0.000724	0.00522	CbGeAlD
Quetiapine—HRH1—testis—testicular cancer	0.000689	0.00496	CbGeAlD
Quetiapine—ADRA2A—testis—testicular cancer	0.000677	0.00488	CbGeAlD
Quetiapine—ADRA2C—lymph node—testicular cancer	0.000615	0.00443	CbGeAlD
Quetiapine—CYP2D6—female gonad—testicular cancer	0.000591	0.00426	CbGeAlD
Quetiapine—HTR2A—testis—testicular cancer	0.000575	0.00415	CbGeAlD
Quetiapine—CYP2D6—testis—testicular cancer	0.000524	0.00378	CbGeAlD
Quetiapine—ABCB1—gonad—testicular cancer	0.000523	0.00377	CbGeAlD
Quetiapine—HRH1—lymph node—testicular cancer	0.000499	0.0036	CbGeAlD
Quetiapine—ADRA2A—lymph node—testicular cancer	0.000491	0.00353	CbGeAlD
Quetiapine—ABCB1—female gonad—testicular cancer	0.000425	0.00306	CbGeAlD
Quetiapine—ABCB1—testis—testicular cancer	0.000377	0.00272	CbGeAlD
Quetiapine—ABCB1—lymph node—testicular cancer	0.000273	0.00197	CbGeAlD
Quetiapine—Jaundice—Doxorubicin—testicular cancer	0.00018	0.000478	CcSEcCtD
Quetiapine—Rhinitis—Epirubicin—testicular cancer	0.000179	0.000477	CcSEcCtD
Quetiapine—Abdominal pain—Etoposide—testicular cancer	0.000179	0.000477	CcSEcCtD
Quetiapine—Body temperature increased—Etoposide—testicular cancer	0.000179	0.000477	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—testicular cancer	0.000179	0.000477	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—testicular cancer	0.000179	0.000477	CcSEcCtD
Quetiapine—Hepatitis—Epirubicin—testicular cancer	0.000179	0.000476	CcSEcCtD
Quetiapine—Haemorrhage—Epirubicin—testicular cancer	0.000179	0.000476	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—testicular cancer	0.000178	0.000476	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—testicular cancer	0.000178	0.000474	CcSEcCtD
Quetiapine—Hypoaesthesia—Epirubicin—testicular cancer	0.000178	0.000474	CcSEcCtD
Quetiapine—Asthenia—Cisplatin—testicular cancer	0.000177	0.000473	CcSEcCtD
Quetiapine—Pharyngitis—Epirubicin—testicular cancer	0.000177	0.000473	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—testicular cancer	0.000177	0.000472	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—testicular cancer	0.000177	0.000471	CcSEcCtD
Quetiapine—Urinary tract disorder—Epirubicin—testicular cancer	0.000177	0.00047	CcSEcCtD
Quetiapine—Oedema peripheral—Epirubicin—testicular cancer	0.000176	0.000469	CcSEcCtD
Quetiapine—Connective tissue disorder—Epirubicin—testicular cancer	0.000176	0.000468	CcSEcCtD
Quetiapine—Urethral disorder—Epirubicin—testicular cancer	0.000175	0.000467	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000174	0.000464	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—testicular cancer	0.000174	0.000463	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—testicular cancer	0.000173	0.000462	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—testicular cancer	0.000173	0.000461	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—testicular cancer	0.000173	0.00046	CcSEcCtD
Quetiapine—Visual impairment—Epirubicin—testicular cancer	0.000172	0.000459	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—testicular cancer	0.000172	0.000459	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—testicular cancer	0.000172	0.000458	CcSEcCtD
Quetiapine—Chills—Methotrexate—testicular cancer	0.000171	0.000457	CcSEcCtD
Quetiapine—Nausea—Ifosfamide—testicular cancer	0.00017	0.000454	CcSEcCtD
Quetiapine—Diarrhoea—Cisplatin—testicular cancer	0.000169	0.000451	CcSEcCtD
Quetiapine—Erythema multiforme—Epirubicin—testicular cancer	0.000169	0.00045	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—testicular cancer	0.000168	0.000449	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—testicular cancer	0.000167	0.000446	CcSEcCtD
Quetiapine—Eye disorder—Epirubicin—testicular cancer	0.000167	0.000445	CcSEcCtD
Quetiapine—Hypersensitivity—Etoposide—testicular cancer	0.000167	0.000445	CcSEcCtD
Quetiapine—Tinnitus—Epirubicin—testicular cancer	0.000167	0.000444	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—testicular cancer	0.000166	0.000443	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—testicular cancer	0.000166	0.000443	CcSEcCtD
Quetiapine—Cardiac disorder—Epirubicin—testicular cancer	0.000166	0.000442	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—testicular cancer	0.000166	0.000442	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—testicular cancer	0.000165	0.000441	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—testicular cancer	0.000165	0.000441	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000165	0.000438	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—testicular cancer	0.000164	0.000437	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000163	0.000435	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—testicular cancer	0.000163	0.000434	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—testicular cancer	0.000163	0.000434	CcSEcCtD
Quetiapine—Asthenia—Etoposide—testicular cancer	0.000163	0.000433	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000163	0.000433	CcSEcCtD
Quetiapine—Angiopathy—Epirubicin—testicular cancer	0.000162	0.000432	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—testicular cancer	0.000162	0.000432	CcSEcCtD
Quetiapine—Immune system disorder—Epirubicin—testicular cancer	0.000161	0.00043	CcSEcCtD
Quetiapine—Mediastinal disorder—Epirubicin—testicular cancer	0.000161	0.000429	CcSEcCtD
Quetiapine—Back pain—Methotrexate—testicular cancer	0.000161	0.000429	CcSEcCtD
Quetiapine—Chills—Epirubicin—testicular cancer	0.00016	0.000427	CcSEcCtD
Quetiapine—Pruritus—Etoposide—testicular cancer	0.00016	0.000427	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—testicular cancer	0.000159	0.000425	CcSEcCtD
Quetiapine—Vomiting—Cisplatin—testicular cancer	0.000157	0.000419	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—testicular cancer	0.000157	0.000418	CcSEcCtD
Quetiapine—Mental disorder—Epirubicin—testicular cancer	0.000157	0.000417	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—testicular cancer	0.000156	0.000417	CcSEcCtD
Quetiapine—Rash—Cisplatin—testicular cancer	0.000156	0.000415	CcSEcCtD
Quetiapine—Dermatitis—Cisplatin—testicular cancer	0.000156	0.000415	CcSEcCtD
Quetiapine—Malnutrition—Epirubicin—testicular cancer	0.000156	0.000415	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—testicular cancer	0.000155	0.000413	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—testicular cancer	0.000155	0.000412	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—testicular cancer	0.000154	0.000411	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—testicular cancer	0.000154	0.000411	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—testicular cancer	0.000154	0.000409	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—testicular cancer	0.000153	0.000409	CcSEcCtD
Quetiapine—Flatulence—Epirubicin—testicular cancer	0.000153	0.000409	CcSEcCtD
Quetiapine—Tension—Epirubicin—testicular cancer	0.000153	0.000407	CcSEcCtD
Quetiapine—Dysgeusia—Epirubicin—testicular cancer	0.000152	0.000406	CcSEcCtD
Quetiapine—Nervousness—Epirubicin—testicular cancer	0.000151	0.000403	CcSEcCtD
Quetiapine—Back pain—Epirubicin—testicular cancer	0.000151	0.000401	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—testicular cancer	0.00015	0.0004	CcSEcCtD
Quetiapine—Malaise—Methotrexate—testicular cancer	0.00015	0.000399	CcSEcCtD
Quetiapine—Dizziness—Etoposide—testicular cancer	0.00015	0.000399	CcSEcCtD
Quetiapine—Muscle spasms—Epirubicin—testicular cancer	0.00015	0.000399	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—testicular cancer	0.000149	0.000398	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—testicular cancer	0.000149	0.000398	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000149	0.000397	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—testicular cancer	0.000149	0.000397	CcSEcCtD
Quetiapine—Chills—Doxorubicin—testicular cancer	0.000148	0.000395	CcSEcCtD
Quetiapine—Nausea—Cisplatin—testicular cancer	0.000147	0.000391	CcSEcCtD
Quetiapine—Vision blurred—Epirubicin—testicular cancer	0.000147	0.000391	CcSEcCtD
Quetiapine—Cough—Methotrexate—testicular cancer	0.000145	0.000387	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—testicular cancer	0.000145	0.000386	CcSEcCtD
Quetiapine—Ill-defined disorder—Epirubicin—testicular cancer	0.000144	0.000385	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—testicular cancer	0.000144	0.000384	CcSEcCtD
Quetiapine—Vomiting—Etoposide—testicular cancer	0.000144	0.000384	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—testicular cancer	0.000144	0.000384	CcSEcCtD
Quetiapine—Anaemia—Epirubicin—testicular cancer	0.000144	0.000383	CcSEcCtD
Quetiapine—Agitation—Epirubicin—testicular cancer	0.000143	0.000381	CcSEcCtD
Quetiapine—Rash—Etoposide—testicular cancer	0.000143	0.000381	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—testicular cancer	0.000143	0.00038	CcSEcCtD
Quetiapine—Headache—Etoposide—testicular cancer	0.000142	0.000378	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—testicular cancer	0.000142	0.000378	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—testicular cancer	0.000142	0.000377	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—testicular cancer	0.000142	0.000377	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—testicular cancer	0.000142	0.000377	CcSEcCtD
Quetiapine—Tension—Doxorubicin—testicular cancer	0.000141	0.000376	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—testicular cancer	0.000141	0.000376	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000141	0.000375	CcSEcCtD
Quetiapine—Malaise—Epirubicin—testicular cancer	0.00014	0.000374	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—testicular cancer	0.00014	0.000373	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—testicular cancer	0.00014	0.000373	CcSEcCtD
Quetiapine—Vertigo—Epirubicin—testicular cancer	0.00014	0.000372	CcSEcCtD
Quetiapine—Syncope—Epirubicin—testicular cancer	0.00014	0.000372	CcSEcCtD
Quetiapine—Leukopenia—Epirubicin—testicular cancer	0.000139	0.000371	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—testicular cancer	0.000139	0.000371	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—testicular cancer	0.000138	0.000369	CcSEcCtD
Quetiapine—Palpitations—Epirubicin—testicular cancer	0.000138	0.000366	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—testicular cancer	0.000137	0.000365	CcSEcCtD
Quetiapine—Loss of consciousness—Epirubicin—testicular cancer	0.000137	0.000364	CcSEcCtD
Quetiapine—Cough—Epirubicin—testicular cancer	0.000136	0.000362	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—testicular cancer	0.000136	0.000362	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—testicular cancer	0.000136	0.000362	CcSEcCtD
Quetiapine—Convulsion—Epirubicin—testicular cancer	0.000135	0.000359	CcSEcCtD
Quetiapine—Infection—Methotrexate—testicular cancer	0.000135	0.000359	CcSEcCtD
Quetiapine—Nausea—Etoposide—testicular cancer	0.000135	0.000359	CcSEcCtD
Quetiapine—Hypertension—Epirubicin—testicular cancer	0.000134	0.000358	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000134	0.000356	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—testicular cancer	0.000133	0.000355	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—testicular cancer	0.000133	0.000355	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—testicular cancer	0.000133	0.000354	CcSEcCtD
Quetiapine—Arthralgia—Epirubicin—testicular cancer	0.000132	0.000353	CcSEcCtD
Quetiapine—Chest pain—Epirubicin—testicular cancer	0.000132	0.000353	CcSEcCtD
Quetiapine—Myalgia—Epirubicin—testicular cancer	0.000132	0.000353	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—testicular cancer	0.000132	0.000353	CcSEcCtD
Quetiapine—Anxiety—Epirubicin—testicular cancer	0.000132	0.000352	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—testicular cancer	0.000132	0.000351	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000132	0.000351	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—testicular cancer	0.000131	0.00035	CcSEcCtD
Quetiapine—Discomfort—Epirubicin—testicular cancer	0.000131	0.000349	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—testicular cancer	0.00013	0.000346	CcSEcCtD
Quetiapine—Dry mouth—Epirubicin—testicular cancer	0.00013	0.000345	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—testicular cancer	0.000129	0.000345	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—testicular cancer	0.000129	0.000345	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—testicular cancer	0.000129	0.000344	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—testicular cancer	0.000129	0.000343	CcSEcCtD
Quetiapine—Confusional state—Epirubicin—testicular cancer	0.000128	0.000341	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—testicular cancer	0.000127	0.000339	CcSEcCtD
Quetiapine—Anaphylactic shock—Epirubicin—testicular cancer	0.000127	0.000338	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—testicular cancer	0.000127	0.000338	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—testicular cancer	0.000127	0.000337	CcSEcCtD
Quetiapine—Infection—Epirubicin—testicular cancer	0.000126	0.000336	CcSEcCtD
Quetiapine—Cough—Doxorubicin—testicular cancer	0.000126	0.000335	CcSEcCtD
Quetiapine—Shock—Epirubicin—testicular cancer	0.000125	0.000333	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—testicular cancer	0.000125	0.000332	CcSEcCtD
Quetiapine—Nervous system disorder—Epirubicin—testicular cancer	0.000125	0.000332	CcSEcCtD
Quetiapine—Thrombocytopenia—Epirubicin—testicular cancer	0.000124	0.000331	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—testicular cancer	0.000124	0.000331	CcSEcCtD
Quetiapine—Tachycardia—Epirubicin—testicular cancer	0.000124	0.00033	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000124	0.000329	CcSEcCtD
Quetiapine—Skin disorder—Epirubicin—testicular cancer	0.000123	0.000329	CcSEcCtD
Quetiapine—Hyperhidrosis—Epirubicin—testicular cancer	0.000123	0.000327	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—testicular cancer	0.000123	0.000327	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—testicular cancer	0.000123	0.000327	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—testicular cancer	0.000123	0.000327	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—testicular cancer	0.000123	0.000327	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—testicular cancer	0.000122	0.000325	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—testicular cancer	0.000122	0.000325	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000122	0.000324	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—testicular cancer	0.000121	0.000323	CcSEcCtD
Quetiapine—Anorexia—Epirubicin—testicular cancer	0.000121	0.000323	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—testicular cancer	0.000121	0.000322	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—testicular cancer	0.000121	0.000321	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—testicular cancer	0.00012	0.000319	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—testicular cancer	0.000119	0.000318	CcSEcCtD
Quetiapine—Hypotension—Epirubicin—testicular cancer	0.000119	0.000316	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—testicular cancer	0.000118	0.000316	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—testicular cancer	0.000118	0.000314	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000118	0.000313	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000117	0.000312	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—testicular cancer	0.000117	0.000312	CcSEcCtD
Quetiapine—Infection—Doxorubicin—testicular cancer	0.000117	0.000311	CcSEcCtD
Quetiapine—Pain—Methotrexate—testicular cancer	0.000116	0.000309	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000116	0.000308	CcSEcCtD
Quetiapine—Shock—Doxorubicin—testicular cancer	0.000116	0.000308	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—testicular cancer	0.000115	0.000307	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000115	0.000307	CcSEcCtD
Quetiapine—Insomnia—Epirubicin—testicular cancer	0.000115	0.000306	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—testicular cancer	0.000115	0.000306	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—testicular cancer	0.000114	0.000304	CcSEcCtD
Quetiapine—Paraesthesia—Epirubicin—testicular cancer	0.000114	0.000304	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000114	0.000303	CcSEcCtD
Quetiapine—Dyspnoea—Epirubicin—testicular cancer	0.000113	0.000302	CcSEcCtD
Quetiapine—Somnolence—Epirubicin—testicular cancer	0.000113	0.000301	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—testicular cancer	0.000112	0.000298	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—testicular cancer	0.000112	0.000298	CcSEcCtD
Quetiapine—Dyspepsia—Epirubicin—testicular cancer	0.000112	0.000298	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000111	0.000296	CcSEcCtD
Quetiapine—Decreased appetite—Epirubicin—testicular cancer	0.00011	0.000294	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—testicular cancer	0.00011	0.000293	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00011	0.000292	CcSEcCtD
Quetiapine—Fatigue—Epirubicin—testicular cancer	0.000109	0.000292	CcSEcCtD
Quetiapine—Pain—Epirubicin—testicular cancer	0.000109	0.000289	CcSEcCtD
Quetiapine—Constipation—Epirubicin—testicular cancer	0.000109	0.000289	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—testicular cancer	0.000107	0.000286	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—testicular cancer	0.000107	0.000286	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000107	0.000285	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—testicular cancer	0.000106	0.000283	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—testicular cancer	0.000106	0.000281	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—testicular cancer	0.000105	0.000279	CcSEcCtD
Quetiapine—Feeling abnormal—Epirubicin—testicular cancer	0.000105	0.000279	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—testicular cancer	0.000104	0.000278	CcSEcCtD
Quetiapine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000104	0.000277	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—testicular cancer	0.000103	0.000276	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—testicular cancer	0.000102	0.000272	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000101	0.00027	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—testicular cancer	0.000101	0.00027	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—testicular cancer	0.0001	0.000268	CcSEcCtD
Quetiapine—Pain—Doxorubicin—testicular cancer	0.0001	0.000268	CcSEcCtD
Quetiapine—Abdominal pain—Epirubicin—testicular cancer	0.0001	0.000267	CcSEcCtD
Quetiapine—Body temperature increased—Epirubicin—testicular cancer	0.0001	0.000267	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—testicular cancer	0.0001	0.000266	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—testicular cancer	9.74e-05	0.000259	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—testicular cancer	9.68e-05	0.000258	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—testicular cancer	9.61e-05	0.000256	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—testicular cancer	9.6e-05	0.000256	CcSEcCtD
Quetiapine—Hypersensitivity—Epirubicin—testicular cancer	9.36e-05	0.000249	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—testicular cancer	9.29e-05	0.000247	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—testicular cancer	9.29e-05	0.000247	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—testicular cancer	9.28e-05	0.000247	CcSEcCtD
Quetiapine—Asthenia—Epirubicin—testicular cancer	9.11e-05	0.000243	CcSEcCtD
Quetiapine—Pruritus—Epirubicin—testicular cancer	8.98e-05	0.000239	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—testicular cancer	8.97e-05	0.000239	CcSEcCtD
Quetiapine—Diarrhoea—Epirubicin—testicular cancer	8.69e-05	0.000232	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—testicular cancer	8.66e-05	0.000231	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—testicular cancer	8.63e-05	0.00023	CcSEcCtD
Quetiapine—Rash—Methotrexate—testicular cancer	8.56e-05	0.000228	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—testicular cancer	8.55e-05	0.000228	CcSEcCtD
Quetiapine—Headache—Methotrexate—testicular cancer	8.5e-05	0.000226	CcSEcCtD
Quetiapine—ADRA2B—GPCR ligand binding—INSL3—testicular cancer	8.44e-05	0.0066	CbGpPWpGaD
Quetiapine—Asthenia—Doxorubicin—testicular cancer	8.43e-05	0.000225	CcSEcCtD
Quetiapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	8.41e-05	0.00658	CbGpPWpGaD
Quetiapine—Dizziness—Epirubicin—testicular cancer	8.4e-05	0.000224	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—testicular cancer	8.31e-05	0.000221	CcSEcCtD
Quetiapine—HTR1E—Signaling by GPCR—INSL3—testicular cancer	8.27e-05	0.00647	CbGpPWpGaD
Quetiapine—HTR1A—GPCR ligand binding—INSL3—testicular cancer	8.15e-05	0.00637	CbGpPWpGaD
Quetiapine—HTR2C—GPCR ligand binding—INSL3—testicular cancer	8.11e-05	0.00634	CbGpPWpGaD
Quetiapine—Vomiting—Epirubicin—testicular cancer	8.07e-05	0.000215	CcSEcCtD
Quetiapine—DRD5—GPCR downstream signaling—INSL3—testicular cancer	8.06e-05	0.0063	CbGpPWpGaD
Quetiapine—Nausea—Methotrexate—testicular cancer	8.06e-05	0.000215	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—testicular cancer	8.04e-05	0.000214	CcSEcCtD
Quetiapine—Rash—Epirubicin—testicular cancer	8.01e-05	0.000213	CcSEcCtD
Quetiapine—Dermatitis—Epirubicin—testicular cancer	8e-05	0.000213	CcSEcCtD
Quetiapine—ADRA2C—Integration of energy metabolism—STK11—testicular cancer	7.96e-05	0.00622	CbGpPWpGaD
Quetiapine—Headache—Epirubicin—testicular cancer	7.96e-05	0.000212	CcSEcCtD
Quetiapine—ADRA2C—GPCR ligand binding—INSL3—testicular cancer	7.89e-05	0.00617	CbGpPWpGaD
Quetiapine—Dizziness—Doxorubicin—testicular cancer	7.77e-05	0.000207	CcSEcCtD
Quetiapine—ADRA1B—GPCR ligand binding—INSL3—testicular cancer	7.76e-05	0.00607	CbGpPWpGaD
Quetiapine—Nausea—Epirubicin—testicular cancer	7.54e-05	0.000201	CcSEcCtD
Quetiapine—CYP3A7—Biological oxidations—HPGDS—testicular cancer	7.54e-05	0.0059	CbGpPWpGaD
Quetiapine—Vomiting—Doxorubicin—testicular cancer	7.47e-05	0.000199	CcSEcCtD
Quetiapine—Rash—Doxorubicin—testicular cancer	7.41e-05	0.000197	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—testicular cancer	7.4e-05	0.000197	CcSEcCtD
Quetiapine—Headache—Doxorubicin—testicular cancer	7.36e-05	0.000196	CcSEcCtD
Quetiapine—DRD5—Signaling by GPCR—INSL3—testicular cancer	7.32e-05	0.00572	CbGpPWpGaD
Quetiapine—DRD2—GPCR ligand binding—INSL3—testicular cancer	7.15e-05	0.0056	CbGpPWpGaD
Quetiapine—CHRM3—Integration of energy metabolism—STK11—testicular cancer	7.04e-05	0.00551	CbGpPWpGaD
Quetiapine—HTR2A—GPCR ligand binding—INSL3—testicular cancer	7.04e-05	0.00551	CbGpPWpGaD
Quetiapine—HRH1—GPCR ligand binding—INSL3—testicular cancer	7.02e-05	0.00549	CbGpPWpGaD
Quetiapine—CHRM1—GPCR ligand binding—INSL3—testicular cancer	7e-05	0.00548	CbGpPWpGaD
Quetiapine—CHRM3—GPCR ligand binding—INSL3—testicular cancer	6.98e-05	0.00546	CbGpPWpGaD
Quetiapine—Nausea—Doxorubicin—testicular cancer	6.98e-05	0.000186	CcSEcCtD
Quetiapine—CHRM2—GPCR ligand binding—INSL3—testicular cancer	6.91e-05	0.00541	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR ligand binding—INSL3—testicular cancer	6.89e-05	0.00539	CbGpPWpGaD
Quetiapine—ADRA2A—Integration of energy metabolism—STK11—testicular cancer	6.46e-05	0.00505	CbGpPWpGaD
Quetiapine—ADRA1B—LPA receptor mediated events—MMP2—testicular cancer	6.46e-05	0.00505	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR ligand binding—INSL3—testicular cancer	6.4e-05	0.00501	CbGpPWpGaD
Quetiapine—HTR6—GPCR downstream signaling—INSL3—testicular cancer	6.22e-05	0.00487	CbGpPWpGaD
Quetiapine—HTR7—GPCR downstream signaling—INSL3—testicular cancer	6.21e-05	0.00486	CbGpPWpGaD
Quetiapine—HTR1D—GPCR downstream signaling—INSL3—testicular cancer	6.17e-05	0.00483	CbGpPWpGaD
Quetiapine—HTR1B—GPCR downstream signaling—INSL3—testicular cancer	6.05e-05	0.00473	CbGpPWpGaD
Quetiapine—DRD4—GPCR downstream signaling—INSL3—testicular cancer	5.95e-05	0.00465	CbGpPWpGaD
Quetiapine—CHRM4—GPCR downstream signaling—INSL3—testicular cancer	5.87e-05	0.00459	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—INSL3—testicular cancer	5.65e-05	0.00442	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—INSL3—testicular cancer	5.64e-05	0.00441	CbGpPWpGaD
Quetiapine—CHRM5—GPCR downstream signaling—INSL3—testicular cancer	5.62e-05	0.0044	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—INSL3—testicular cancer	5.61e-05	0.00439	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—INSL3—testicular cancer	5.49e-05	0.00429	CbGpPWpGaD
Quetiapine—CYP3A5—Biological oxidations—HPGDS—testicular cancer	5.45e-05	0.00426	CbGpPWpGaD
Quetiapine—CHRM4—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	5.4e-05	0.00423	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—INSL3—testicular cancer	5.4e-05	0.00423	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—INSL3—testicular cancer	5.36e-05	0.00419	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—INSL3—testicular cancer	5.33e-05	0.00417	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—INSL3—testicular cancer	5.28e-05	0.00413	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—INSL3—testicular cancer	5.28e-05	0.00413	CbGpPWpGaD
Quetiapine—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	5.18e-05	0.00405	CbGpPWpGaD
Quetiapine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	5.15e-05	0.00403	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—INSL3—testicular cancer	5.1e-05	0.00399	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—INSL3—testicular cancer	4.89e-05	0.00382	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—INSL3—testicular cancer	4.86e-05	0.0038	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—INSL3—testicular cancer	4.8e-05	0.00375	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—INSL3—testicular cancer	4.8e-05	0.00375	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—INSL3—testicular cancer	4.77e-05	0.00373	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—INSL3—testicular cancer	4.61e-05	0.0036	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—INSL3—testicular cancer	4.58e-05	0.00358	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—INSL3—testicular cancer	4.46e-05	0.00349	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—INSL3—testicular cancer	4.39e-05	0.00343	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—INSL3—testicular cancer	4.33e-05	0.00339	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—INSL3—testicular cancer	4.32e-05	0.00338	CbGpPWpGaD
Quetiapine—CYP2C19—Biological oxidations—HPGDS—testicular cancer	4.21e-05	0.0033	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—INSL3—testicular cancer	4.18e-05	0.00327	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—INSL3—testicular cancer	4.16e-05	0.00325	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.14e-05	0.00324	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—INSL3—testicular cancer	4.05e-05	0.00317	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—INSL3—testicular cancer	4.04e-05	0.00316	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—INSL3—testicular cancer	3.98e-05	0.00311	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—INSL3—testicular cancer	3.98e-05	0.00311	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—INSL3—testicular cancer	3.97e-05	0.00311	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—INSL3—testicular cancer	3.96e-05	0.0031	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—INSL3—testicular cancer	3.94e-05	0.00309	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—INSL3—testicular cancer	3.91e-05	0.00306	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—INSL3—testicular cancer	3.9e-05	0.00305	CbGpPWpGaD
Quetiapine—CYP2D6—Biological oxidations—HPGDS—testicular cancer	3.88e-05	0.00303	CbGpPWpGaD
Quetiapine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	3.78e-05	0.00296	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—INSL3—testicular cancer	3.67e-05	0.00287	CbGpPWpGaD
Quetiapine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	3.64e-05	0.00285	CbGpPWpGaD
Quetiapine—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	3.63e-05	0.00284	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—INSL3—testicular cancer	3.62e-05	0.00283	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—INSL3—testicular cancer	3.61e-05	0.00283	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—INSL3—testicular cancer	3.61e-05	0.00282	CbGpPWpGaD
Quetiapine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—testicular cancer	3.6e-05	0.00281	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—INSL3—testicular cancer	3.59e-05	0.00281	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—INSL3—testicular cancer	3.58e-05	0.0028	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—INSL3—testicular cancer	3.55e-05	0.00277	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—INSL3—testicular cancer	3.54e-05	0.00277	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—INSL3—testicular cancer	3.34e-05	0.00261	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—INSL3—testicular cancer	3.33e-05	0.00261	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—INSL3—testicular cancer	3.31e-05	0.00259	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—INSL3—testicular cancer	3.29e-05	0.00257	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—INSL3—testicular cancer	3.24e-05	0.00254	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—INSL3—testicular cancer	3.19e-05	0.0025	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—INSL3—testicular cancer	3.15e-05	0.00246	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—INSL3—testicular cancer	3.01e-05	0.00236	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—INSL3—testicular cancer	2.87e-05	0.00225	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—INSL3—testicular cancer	2.83e-05	0.00222	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—INSL3—testicular cancer	2.83e-05	0.00222	CbGpPWpGaD
Quetiapine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	2.75e-05	0.00215	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—INSL3—testicular cancer	2.56e-05	0.002	CbGpPWpGaD
Quetiapine—CYP3A4—Biological oxidations—HPGDS—testicular cancer	2.53e-05	0.00198	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—INSL3—testicular cancer	2.47e-05	0.00193	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—INSL3—testicular cancer	2.46e-05	0.00192	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—INSL3—testicular cancer	2.39e-05	0.00187	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—INSL3—testicular cancer	2.35e-05	0.00184	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—INSL3—testicular cancer	2.17e-05	0.0017	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—INSL3—testicular cancer	2.13e-05	0.00167	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—INSL3—testicular cancer	2.13e-05	0.00167	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—INSL3—testicular cancer	2.12e-05	0.00166	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—INSL3—testicular cancer	2.12e-05	0.00166	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—INSL3—testicular cancer	2.1e-05	0.00164	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—INSL3—testicular cancer	2.09e-05	0.00163	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—INSL3—testicular cancer	1.94e-05	0.00152	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.62e-05	0.00127	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—H2AFZ—testicular cancer	1.56e-05	0.00122	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—STK11—testicular cancer	1.55e-05	0.00122	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—KITLG—testicular cancer	1.44e-05	0.00113	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—H2AFZ—testicular cancer	1.38e-05	0.00108	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—STK11—testicular cancer	1.38e-05	0.00108	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—HPGDS—testicular cancer	1.29e-05	0.00101	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—KITLG—testicular cancer	1.27e-05	0.000996	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—HPGDS—testicular cancer	1.25e-05	0.000979	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—HPGDS—testicular cancer	1.11e-05	0.000867	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—FGFR3—testicular cancer	1.07e-05	0.000836	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—H2AFZ—testicular cancer	1.07e-05	0.000836	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—H2AFZ—testicular cancer	1.07e-05	0.000835	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—STK11—testicular cancer	1.06e-05	0.000831	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—STK11—testicular cancer	1.06e-05	0.00083	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—H2AFZ—testicular cancer	1.06e-05	0.000829	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—STK11—testicular cancer	1.05e-05	0.000824	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—H2AFZ—testicular cancer	1.04e-05	0.000812	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—STK11—testicular cancer	1.03e-05	0.000807	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—H2AFZ—testicular cancer	1.02e-05	0.000799	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—HPGDS—testicular cancer	1.02e-05	0.000796	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—STK11—testicular cancer	1.02e-05	0.000794	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—H2AFZ—testicular cancer	1.01e-05	0.000788	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—STK11—testicular cancer	1e-05	0.000784	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KITLG—testicular cancer	9.83e-06	0.000769	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KITLG—testicular cancer	9.82e-06	0.000768	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—KIT—testicular cancer	9.82e-06	0.000768	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KITLG—testicular cancer	9.75e-06	0.000763	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—H2AFZ—testicular cancer	9.65e-06	0.000755	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—STK11—testicular cancer	9.6e-06	0.00075	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KITLG—testicular cancer	9.55e-06	0.000747	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—FGFR3—testicular cancer	9.46e-06	0.00074	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KITLG—testicular cancer	9.4e-06	0.000735	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—STK11—testicular cancer	9.37e-06	0.000733	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—HPGDS—testicular cancer	9.32e-06	0.000729	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KITLG—testicular cancer	9.27e-06	0.000725	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—H2AFZ—testicular cancer	9.2e-06	0.000719	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STK11—testicular cancer	9.14e-06	0.000715	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—STK11—testicular cancer	9.1e-06	0.000712	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—H2AFZ—testicular cancer	9.07e-06	0.00071	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—H2AFZ—testicular cancer	9.07e-06	0.00071	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STK11—testicular cancer	9.02e-06	0.000706	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STK11—testicular cancer	9.02e-06	0.000706	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KITLG—testicular cancer	8.88e-06	0.000694	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—KIT—testicular cancer	8.69e-06	0.00068	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KITLG—testicular cancer	8.46e-06	0.000662	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KITLG—testicular cancer	8.35e-06	0.000653	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KITLG—testicular cancer	8.35e-06	0.000653	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—H2AFZ—testicular cancer	8.19e-06	0.000641	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STK11—testicular cancer	8.14e-06	0.000637	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—STK11—testicular cancer	8.05e-06	0.00063	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—H2AFZ—testicular cancer	7.91e-06	0.000619	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—H2AFZ—testicular cancer	7.87e-06	0.000615	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STK11—testicular cancer	7.86e-06	0.000615	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STK11—testicular cancer	7.82e-06	0.000612	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—H2AFZ—testicular cancer	7.65e-06	0.000598	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STK11—testicular cancer	7.61e-06	0.000595	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KITLG—testicular cancer	7.54e-06	0.000589	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—H2AFZ—testicular cancer	7.53e-06	0.000589	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STK11—testicular cancer	7.49e-06	0.000586	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—STK11—testicular cancer	7.39e-06	0.000578	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—FGFR3—testicular cancer	7.3e-06	0.000571	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—FGFR3—testicular cancer	7.3e-06	0.000571	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KITLG—testicular cancer	7.27e-06	0.000569	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—FGFR3—testicular cancer	7.25e-06	0.000567	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KITLG—testicular cancer	7.24e-06	0.000566	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—HPGDS—testicular cancer	7.21e-06	0.000564	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—FGFR3—testicular cancer	7.1e-06	0.000555	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KITLG—testicular cancer	7.04e-06	0.000551	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—HPGDS—testicular cancer	7.03e-06	0.00055	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—FGFR3—testicular cancer	6.98e-06	0.000546	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—H2AFZ—testicular cancer	6.94e-06	0.000543	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KITLG—testicular cancer	6.93e-06	0.000542	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STK11—testicular cancer	6.9e-06	0.00054	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—FGFR3—testicular cancer	6.89e-06	0.000539	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—H2AFZ—testicular cancer	6.83e-06	0.000534	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—H2AFZ—testicular cancer	6.82e-06	0.000533	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—H2AFZ—testicular cancer	6.8e-06	0.000531	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STK11—testicular cancer	6.79e-06	0.000531	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STK11—testicular cancer	6.78e-06	0.00053	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—H2AFZ—testicular cancer	6.77e-06	0.00053	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—STK11—testicular cancer	6.77e-06	0.00053	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STK11—testicular cancer	6.76e-06	0.000528	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STK11—testicular cancer	6.73e-06	0.000527	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—H2AFZ—testicular cancer	6.71e-06	0.000525	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—KIT—testicular cancer	6.71e-06	0.000525	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—KIT—testicular cancer	6.7e-06	0.000524	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—H2AFZ—testicular cancer	6.69e-06	0.000523	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STK11—testicular cancer	6.67e-06	0.000522	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—KIT—testicular cancer	6.66e-06	0.000521	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STK11—testicular cancer	6.65e-06	0.00052	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—HPGDS—testicular cancer	6.63e-06	0.000518	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—FGFR3—testicular cancer	6.6e-06	0.000516	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KIT—testicular cancer	6.52e-06	0.00051	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KIT—testicular cancer	6.41e-06	0.000502	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KITLG—testicular cancer	6.39e-06	0.0005	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KIT—testicular cancer	6.33e-06	0.000495	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—FGFR3—testicular cancer	6.29e-06	0.000492	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KITLG—testicular cancer	6.28e-06	0.000492	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KITLG—testicular cancer	6.27e-06	0.000491	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KITLG—testicular cancer	6.25e-06	0.000489	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KITLG—testicular cancer	6.23e-06	0.000487	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—H2AFZ—testicular cancer	6.22e-06	0.000486	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—FGFR3—testicular cancer	6.2e-06	0.000485	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—FGFR3—testicular cancer	6.2e-06	0.000485	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STK11—testicular cancer	6.18e-06	0.000483	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KITLG—testicular cancer	6.17e-06	0.000483	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KITLG—testicular cancer	6.15e-06	0.000481	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KIT—testicular cancer	6.06e-06	0.000474	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KIT—testicular cancer	5.77e-06	0.000452	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KITLG—testicular cancer	5.72e-06	0.000447	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KIT—testicular cancer	5.7e-06	0.000445	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KIT—testicular cancer	5.7e-06	0.000445	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—FGFR3—testicular cancer	5.6e-06	0.000438	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—FGFR3—testicular cancer	5.41e-06	0.000423	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—FGFR3—testicular cancer	5.38e-06	0.000421	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—STK11—testicular cancer	5.24e-06	0.00041	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—FGFR3—testicular cancer	5.23e-06	0.000409	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—FGFR3—testicular cancer	5.15e-06	0.000403	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KIT—testicular cancer	5.14e-06	0.000402	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—STK11—testicular cancer	5.11e-06	0.0004	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KIT—testicular cancer	4.96e-06	0.000388	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KIT—testicular cancer	4.94e-06	0.000386	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—STK11—testicular cancer	4.82e-06	0.000377	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KIT—testicular cancer	4.8e-06	0.000376	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—FGFR3—testicular cancer	4.75e-06	0.000371	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KIT—testicular cancer	4.73e-06	0.00037	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—FGFR3—testicular cancer	4.67e-06	0.000365	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—FGFR3—testicular cancer	4.66e-06	0.000365	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—FGFR3—testicular cancer	4.65e-06	0.000363	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—FGFR3—testicular cancer	4.63e-06	0.000362	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—FGFR3—testicular cancer	4.59e-06	0.000359	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—FGFR3—testicular cancer	4.57e-06	0.000358	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KIT—testicular cancer	4.36e-06	0.000341	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—HPGDS—testicular cancer	4.33e-06	0.000339	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KIT—testicular cancer	4.29e-06	0.000335	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KIT—testicular cancer	4.28e-06	0.000335	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KIT—testicular cancer	4.27e-06	0.000334	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KIT—testicular cancer	4.25e-06	0.000333	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—FGFR3—testicular cancer	4.25e-06	0.000332	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KIT—testicular cancer	4.21e-06	0.000329	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KIT—testicular cancer	4.2e-06	0.000328	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KIT—testicular cancer	3.9e-06	0.000305	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—STK11—testicular cancer	3.15e-06	0.000246	CbGpPWpGaD
